Review
doi: 10.1111/j.1755-148X.2008.00478.x. Epub 2008 May 27.G-protein-coupled receptors and melanoma
Affiliations
- PMID:18582227
- PMCID: PMC2843908
- DOI: 10.1111/j.1755-148X.2008.00478.x
Item in Clipboard
Review
G-protein-coupled receptors and melanoma
Hwa Jin Lee et al. Pigment Cell Melanoma Res.2008 Aug.
Display options
Format
Display options
Format
Abstract
G-protein-coupled receptors (GPCR) are the largest family of receptors with over 500 members. Evaluation of GPCR gene expression in primary human tumors identified over-expression of GPCR in several tumor types. Analysis of cancer samples in different disease stages also suggests that some GPCR may be involved in early tumor progression and others may play a critical role in tumor invasion and metastasis. Currently, >50% of drug targets to various human diseases are based on GPCR. In this review, the relationships between several GPCR and melanoma development and/or progression will be discussed. Finally, the possibility of using one or more of these GPCR as therapeutic targets in melanoma will be summarized.
Similar articles
- Overexpression of G protein-coupled receptors in cancer cells: involvement in tumor progression.Li S, Huang S, Peng SB.Li S, et al.Int J Oncol. 2005 Nov;27(5):1329-39.Int J Oncol. 2005.PMID:16211229Review.
- Involvement of metabotropic glutamate receptor 1, a G protein coupled receptor, in melanoma development.Marín YE, Chen S.Marín YE, et al.J Mol Med (Berl). 2004 Nov;82(11):735-49. doi: 10.1007/s00109-004-0566-8. Epub 2004 Aug 21.J Mol Med (Berl). 2004.PMID:15322701Review.
- Remarkable similarities between the hemichordate (Saccoglossus kowalevskii) and vertebrate GPCR repertoire.Krishnan A, Almén MS, Fredriksson R, Schiöth HB.Krishnan A, et al.Gene. 2013 Sep 10;526(2):122-33. doi: 10.1016/j.gene.2013.05.005. Epub 2013 May 15.Gene. 2013.PMID:23685280
- Quantitative expression profiling of G-protein-coupled receptors (GPCRs) in metastatic melanoma: the constitutively active orphan GPCR GPR18 as novel drug target.Qin Y, Verdegaal EM, Siderius M, Bebelman JP, Smit MJ, Leurs R, Willemze R, Tensen CP, Osanto S.Qin Y, et al.Pigment Cell Melanoma Res. 2011 Feb;24(1):207-18. doi: 10.1111/j.1755-148X.2010.00781.x. Epub 2010 Oct 21.Pigment Cell Melanoma Res. 2011.PMID:20880198
- Genetic variation in G-protein-coupled receptors--consequences for G-protein-coupled receptors as drug targets.Tang CM, Insel PA.Tang CM, et al.Expert Opin Ther Targets. 2005 Dec;9(6):1247-65. doi: 10.1517/14728222.9.6.1247.Expert Opin Ther Targets. 2005.PMID:16300474Review.
Cited by
- Exogenous Hormone Factors in Relation to the Risk of Malignant Melanoma in Women: A Systematic Review and Meta-Analysis.Chiavarini M, Naldini G, Giacchetta I, Fabiani R.Chiavarini M, et al.Cancers (Basel). 2022 Jun 29;14(13):3192. doi: 10.3390/cancers14133192.Cancers (Basel). 2022.PMID:35804961Free PMC article.Review.
- Network-guided analysis of genes with altered somatic copy number and gene expression reveals pathways commonly perturbed in metastatic melanoma.Valsesia A, Rimoldi D, Martinet D, Ibberson M, Benaglio P, Quadroni M, Waridel P, Gaillard M, Pidoux M, Rapin B, Rivolta C, Xenarios I, Simpson AJ, Antonarakis SE, Beckmann JS, Jongeneel CV, Iseli C, Stevenson BJ.Valsesia A, et al.PLoS One. 2011 Apr 8;6(4):e18369. doi: 10.1371/journal.pone.0018369.PLoS One. 2011.PMID:21494657Free PMC article.
- Editorial: GPCRs and Cancer.Chen S.Chen S.Front Genet. 2017 Oct 31;8:162. doi: 10.3389/fgene.2017.00162. eCollection 2017.Front Genet. 2017.PMID:29163632Free PMC article.No abstract available.
- ERK and PDE4 cooperate to induce RAF isoform switching in melanoma.Marquette A, André J, Bagot M, Bensussan A, Dumaz N.Marquette A, et al.Nat Struct Mol Biol. 2011 May;18(5):584-91. doi: 10.1038/nsmb.2022. Epub 2011 Apr 10.Nat Struct Mol Biol. 2011.PMID:21478863
- RAF-isotype switching: from B to C through PDE.Lau E, Ronai Z.Lau E, et al.Nat Struct Mol Biol. 2011 May;18(5):517-8. doi: 10.1038/nsmb.2063.Nat Struct Mol Biol. 2011.PMID:21540889Free PMC article.
References
- Abdel-Malek Z, Suzuki I, Tada A, Im S, Akcali C. The melanocortin-1 receptor and human pigmentation. Ann. N Y Acad. Sci. 1999;885:117–133. - PubMed
- Abdel-Malek Z, Scott MC, Suzuki I, Tada A, Im S, Lamoreux L, Ito S, Barsh G, Hearing VJ. The melanocortin-1 receptor is a key regulator of human cutaneous pigmentation. Pigment Cell Res. 2000;13(Suppl 8):156–162. - PubMed
- Aramori I, Nakanishi S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron. 1992;8:757–765. - PubMed
- Asanuma K, Wakabayashi H, Hayashi T, Okuyama N, Seto M, Matsumine A, Kusuzaki K, Suzuki K, Uchida A. Thrombin inhibitor, argatroban, prevents tumor cell migration and bone metastasis. Oncology. 2004;67:166–173. - PubMed
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Medical